Skip to main content
Equibles

BNP PARIBAS ARBITRAGE, SA

Position in NERV — Minerva Neurosciences, Inc.

CIK 1166588 NEW YORK, NY
Back to NERV Full portfolio

Position in NERV

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$43,806
+$43,433 QoQ
Shares Held
7,893
+12630.6% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 58 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in NERV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BNP PARIBAS ARBITRAGE, SA holds $3,331,911,027 across 414 Biotechnology names. NERV ranks #280 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MRNA
Moderna, Inc.
 4,377,120 $306,529,713
2 REGN
Regeneron Pharmaceuticals, Inc.
 399,847 $249,320,598
3 ARGX
Argenx SE
 157,958 $146,548,693
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 262,258 $130,271,416
5 BNTX
BioNTech SE
 1,319,517 $122,781,056
6 RVMD
Revolution Medicines, Inc.
 552,710 $103,511,528
7 ORKA
Oruka Therapeutics, Inc.
 1,079,015 $102,689,857
8 BBIO
BridgeBio Pharma, Inc.
 1,155,442 $86,057,320

All Filings in NERV

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $43,806 7,893
2026-03-31 $373 62
2025-12-31 $249 62
2025-09-30 $130 62
2025-06-30 $106 62
2025-03-31 $105 62
2024-12-31 $137 62
2022-03-31 $442 533
2021-12-31 $426 533
2021-09-30 $1,007 579
2021-06-30 $1,343 579
2021-03-31 $13,423 4,597
2020-12-31 $17,117 7,315
2020-09-30 $25,910 8,148
2020-06-30 $8,999 2,493
2020-03-31 $58,604 9,735